Search

everythinglearnresearchcommunity

for

Search:↓

TCDD changes skin cell growth and keratin production in mice.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

TrichoSol™ effectively stabilizes various hair treatment ingredients for different durations.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

A woman's severe skin reaction was caused by an allergy to a skin treatment.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Selenium therapy improved health in cystic fibrosis patients with fewer side effects at a lower dose.

Thyroid hormone (T3) may reverse gray hair by stimulating hair growth.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The 1927 nm Thulium laser effectively and safely treats postinflammatory hyperpigmentation in darker skin tones.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Early diagnosis and treatment of TPP can prevent complications.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

The new drug delivery system effectively targets lung cancer cells.

Regulatory T cells are essential for normal and improved wound healing in mice.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Frequent blood transfusions in beta thalassemia can lead to thyroid problems.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Upadacitinib improved multiple immune-related conditions in one patient.

Imiquimod cream 5% effectively treated generalized discoid lupus erythematosus.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.